Product Code: PM4280
The global infectious disease diagnostic market size is expected to reach USD 42.39 Billion by 2032, according to a new study by Polaris Market Research. The report "Infectious Disease Diagnostic Market Share, Size, Trends, Industry Analysis Report, By Product; By Type of Testing (Laboratory Testing, PoC Testing); By Technology; By Disease Type; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global market for infectious disease diagnostics is rapidly expanding due to technological advancements, the rising prevalence of infectious diseases, and growing awareness of the importance of early detection and treatment. The emergence of new diseases, combined with the threat of pandemics, has increased demand for rapid and accurate diagnostic tests. Technological advancements in molecular diagnostics, such as next-generation sequencing, PCR-based assays, and point-of-care testing, have significantly improved diagnostic test speed and accuracy, lowered costs, and increased accessibility.
Despite this, the expensive nature of advanced diagnostic tests is a major barrier to market growth, and as a result, their adoption is limited in resource-poor areas. Furthermore, increasing knowledge and access to medical care in developing countries reduces the need for infectious disease diagnostic tests.
Infectious diseases like COVID-19, influenza, and hepatitis continue to pose a significant threat to public health globally. The importance of accurate and timely diagnosis cannot be overstated since it is crucial in preventing further transmission and reducing the risk of outbreaks. To this end, prominent players in the market, such as Abbott Laboratories, bioMerieux, Roche Diagnostics, and Cepheid, are focusing on developing innovative diagnostic solutions that can detect a wide range of infectious diseases, including viral, bacterial, and fungal infections.
Infectious Disease Diagnostic Market Report Highlights
In 2023, the reagents, kits, and consumables generated the highest revenue share within the product segment. This is mainly attributable to the growing incidence of infectious diseases, resulting in a corresponding increase in demand for diagnostic tests. As a result, sales of reagents, kits, and consumables have surged, driving up their revenue share in the market.
In 2023, the laboratory testing segment held the major share of the market, and this was due to the critical role played by laboratory testing in identifying and tracking various infectious diseases.
The market has been significantly influenced by the pandemic, with COVID-19 being the dominating segment in disease type. This is attributed to the massive scale of the pandemic and the critical requirement for precise and prompt diagnosis of the virus.
In 2023, the North American region take the lead position, thanks to the strong healthcare infrastructure and advanced medical facilities in countries like the United States and Canada. These factors played a significant role in contributing to the region's market share.
The global key market players include Abbott, Becton Dickinson, bioMerieux, Bio-Rad Laboratories, Cepheid, Danaher, F. Hoffmann-La Roche Ltd, Hologic Inc., Luminex Corporation, Qiagen Inc., Thermo Fisher Scientific Inc., etc.
Polaris Market Research has segmented the infectious disease diagnostic market report based on product, type of testing, technology, disease type, end user, and region:
Infectious Disease Diagnostic, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Reagents, Kits, and Consumables
- Instruments
- Software and Services
Infectious Disease Diagnostic, Type of Testing Outlook (Revenue - USD Billion, 2019 - 2032)
- Laboratory Testing
- PoC Testing
Infectious Disease Diagnostic, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Clinical Microbiology
- DNA Microarray
- DNA sequencing and Next-generation sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Polymerase Chain Reaction
- Others
Infectious Disease Diagnostic, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)
- COVID-19
- Hepatitis
- HIV
- Hospital-acquired Infections
- HPV
- Influenza
- Mosquito-borne diseases
- Syphilis
- Others
Infectious Disease Diagnostic, End User Outlook (Revenue - USD Billion, 2019 - 2032)
- Academic Research Institutes
- Diagnostics Laboratories
- Hospitals and Clinics
- Others
Infectious Disease Diagnostic, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Infectious Disease Diagnostic Market Insights
- 4.1. Infectious Disease Diagnostic - Industry Snapshot
- 4.2. Infectious Disease Diagnostic Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. The increasing prevalence of infectious diseases drives market growth
- 4.2.1.2. Advancements in technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. The high cost of advanced diagnostic tests limits market growth
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Infectious Disease Diagnostic Industry Trends
- 4.6. COVID-19 Impact Analysis
5. Global Infectious Disease Diagnostic Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 5.3. Reagents, Kits, and Consumables
- 5.3.1. Global Infectious Disease Diagnostic Market, by Reagents, Kits, and Consumables, by Region, 2019-2032 (USD Billion)
- 5.4. Instruments
- 5.4.1. Global Infectious Disease Diagnostic Market, by Instruments, by Region, 2019-2032 (USD Billion)
- 5.5. Software and Services
- 5.5.1. Global Infectious Disease Diagnostic Market, by Software and Services, by Region, 2019-2032 (USD Billion)
6. Global Infectious Disease Diagnostic Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Clinical Microbiology
- 6.3.1. Global Infectious Disease Diagnostic Market, by Clinical Microbiology, by Region, 2019-2032 (USD Billion)
- 6.4. DNA Microarray
- 6.4.1. Global Infectious Disease Diagnostic Market, by DNA Microarray, by Region, 2019-2032 (USD Billion)
- 6.5. DNA sequencing and Next-generation sequencing
- 6.5.1. Global Infectious Disease Diagnostic Market, by DNA sequencing and Next-generation sequencing, by Region, 2019-2032 (USD Billion)
- 6.6. Immunodiagnostics
- 6.6.1. Global Infectious Disease Diagnostic Market, by Immunodiagnostics, by Region, 2019-2032 (USD Billion)
- 6.7. Isothermal Nucleic Acid Amplification Technology
- 6.7.1. Global Infectious Disease Diagnostic Market, by Isothermal Nucleic Acid Amplification Technology, by Region, 2019-2032 (USD Billion)
- 6.8. Polymerase Chain Reaction
- 6.8.1. Global Infectious Disease Diagnostic Market, by Polymerase Chain Reaction, by Region, 2019-2032 (USD Billion)
- 6.9. Others
- 6.9.1. Global Infectious Disease Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Infectious Disease Diagnostic Market, by Type of Testing
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 7.3. Laboratory Testing
- 7.3.1. Global Infectious Disease Diagnostic Market, by Laboratory Testing, by Region, 2019-2032 (USD Billion)
- 7.4. PoC Testing
- 7.4.1. Global Infectious Disease Diagnostic Market, by PoC Testingby Region, 2019-2032 (USD Billion)
8. Global Infectious Disease Diagnostic Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 8.3. Academic Research Institutes
- 8.3.1. Global Infectious Disease Diagnostic Market, by Academic Research Institutes, by Region, 2019-2032 (USD Billion)
- 8.4. Diagnostics Laboratories
- 8.4.1. Global Infectious Disease Diagnostic Market, by Diagnostics Laboratories, by Region, 2019-2032 (USD Billion)
- 8.5. Hospitals and Clinics
- 8.5.1. Global Infectious Disease Diagnostic Market, by Hospitals and Clinics, by Region, 2019-2032 (USD Billion)
- 8.6. Others
- 8.6.1. Global Infectious Disease Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Infectious Disease Diagnostic Market, by Disease Type
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 9.3. COVID-19
- 9.3.1. Global Infectious Disease Diagnostic Market, by COVID-19, by Region, 2019-2032 (USD Billion)
- 9.4. Hepatitis
- 9.4.1. Global Infectious Disease Diagnostic Market, by Hepatitis, by Region, 2019-2032 (USD Billion)
- 9.5. HIV
- 9.5.1. Global Infectious Disease Diagnostic Market, by HIV, by Region, 2019-2032 (USD Billion)
- 9.6. Hospital-acquired Infections
- 9.6.1. Global Infectious Disease Diagnostic Market, by Hospital-acquired Infections, by Region, 2019-2032 (USD Billion)
- 9.7. HPV
- 9.7.1. Global Infectious Disease Diagnostic Market, by HPV, by Region, 2019-2032 (USD Billion)
- 9.8. Influenza
- 9.8.1. Global Infectious Disease Diagnostic Market, by Influenza, by Region, 2019-2032 (USD Billion)
- 9.9. Mosquito-borne diseases
- 9.9.1. Global Infectious Disease Diagnostic Market, by Mosquito-borne diseases, by Region, 2019-2032 (USD Billion)
- 9.10. Syphilis
- 9.10.1. Global Infectious Disease Diagnostic Market, by Syphilis, by Region, 2019-2032 (USD Billion)
- 9.11. Others
- 9.11.1. Global Infectious Disease Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)
10. Global Infectious Disease Diagnostic Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. Infectious Disease Diagnostic Market Assessment, By Geography, 2019-2032 (USD Billion)
- 10.3. Infectious Disease Diagnostic Market - North America
- 10.3.1. North America: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.3.2. North America: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.3.3. North America: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.3.4. North America: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.3.5. North America: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.3.6. Infectious Disease Diagnostic Market - U.S.
- 10.3.6.1. U.S.: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.3.6.2. U.S.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.3.6.3. U.S.: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.3.6.4. U.S.: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.3.6.5. U.S.: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.3.7. Infectious Disease Diagnostic Market - Canada
- 10.3.7.1. Canada: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.3.7.2. Canada.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.3.7.3. Canada: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.3.7.4. Canada: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.3.7.5. Canada: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4. Infectious Disease Diagnostic Market - Europe
- 10.4.1. Europe: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.2. Europe.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.3. Europe: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.4. Europe: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.5. Europe: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.6. Infectious Disease Diagnostic Market - UK
- 10.4.6.1. UK: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.6.2. UK.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.6.3. UK: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.6.4. UK: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.6.5. UK: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.7. Infectious Disease Diagnostic Market - France
- 10.4.7.1. France: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.7.2. France.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.7.3. France: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.7.4. France: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.7.5. France: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.8. Infectious Disease Diagnostic Market - Germany
- 10.4.8.1. Germany: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.8.2. Germany.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.8.3. Germany: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.8.4. Germany: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.8.5. Germany: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.9. Infectious Disease Diagnostic Market - Italy
- 10.4.9.1. Italy: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.9.2. Italy.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.9.3. Italy: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.9.4. Italy: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.9.5. Italy: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.10. Infectious Disease Diagnostic Market - Spain
- 10.4.10.1. Spain: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.10.2. Spain.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.10.3. Spain: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.10.4. Spain: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.10.5. Spain: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.11. Infectious Disease Diagnostic Market - Netherlands
- 10.4.11.1. Netherlands: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.11.2. Netherlands.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.11.3. Netherlands: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.11.4. Netherlands: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.11.5. Netherlands: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.4.12. Infectious Disease Diagnostic Market - Russia
- 10.4.12.1. Russia: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.4.12.2. Russia.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.4.12.3. Russia: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.4.12.4. Russia: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.4.12.5. Russia: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5. Infectious Disease Diagnostic Market - Asia Pacific
- 10.5.1. Asia Pacific: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.2. Asia Pacific.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.3. Asia Pacific: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.4. Asia Pacific: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.5. Asia Pacific: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5.6. Infectious Disease Diagnostic Market - China
- 10.5.6.1. China: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.6.2. China.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.6.3. China: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.6.4. China: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.6.5. China: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5.7. Infectious Disease Diagnostic Market - India
- 10.5.7.1. India: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.7.2. India.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.7.3. India: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.7.4. India: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.7.5. India: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5.8. Infectious Disease Diagnostic Market - Japan
- 10.5.8.1. Japan: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.8.2. Japan.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.8.3. Japan: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.8.4. Japan: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.8.5. Japan: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5.9. Infectious Disease Diagnostic Market - Malaysia
- 10.5.9.1. Malaysia: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.9.2. Malaysia.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.9.3. Malaysia: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.9.4. Malaysia: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.9.5. Malaysia: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5.10. Infectious Disease Diagnostic Market - Indonesia
- 10.5.10.1. Indonesia: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.10.2. Indonesia.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.10.3. Indonesia: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.10.4. Indonesia: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.10.5. Indonesia: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.5.11. Infectious Disease Diagnostic Market - South Korea
- 10.5.11.1. South Korea: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.5.11.2. South Korea.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.5.11.3. South Korea: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.5.11.4. South Korea: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.5.11.5. South Korea: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.6. Infectious Disease Diagnostic Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.6.2. Middle East & Africa: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.6.3. Middle East & Africa: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.6.4. Middle East & Africa: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.6.5. Middle East & Africa: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.6.6. Infectious Disease Diagnostic Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.6.6.2. Saudi Arabia.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.6.6.3. Saudi Arabia: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.6.6.4. Saudi Arabia: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.6.6.5. Saudi Arabia: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.6.7. Infectious Disease Diagnostic Market - UAE
- 10.6.7.1. UAE: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.6.7.2. UAE.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.6.7.3. UAE: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.6.7.4. UAE: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.6.7.5. UAE: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.6.8. Infectious Disease Diagnostic Market - Israel
- 10.6.8.1. Israel: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.6.8.2. Israel.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.6.8.3. Israel: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.6.8.4. Israel: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.6.8.5. Israel: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.6.9. Infectious Disease Diagnostic Market - South Africa
- 10.6.9.1. South Africa: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.6.9.2. South Africa.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.6.9.3. South Africa: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.6.9.4. South Africa: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.6.9.5. South Africa: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.7. Infectious Disease Diagnostic Market - Latin America
- 10.7.1. Latin America: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.7.2. Latin America.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.7.3. Latin America: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.7.4. Latin America: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.7.5. Latin America: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.7.6. Infectious Disease Diagnostic Market - Mexico
- 10.7.6.1. Mexico: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.7.6.2. Mexico.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.7.6.3. Mexico: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.7.6.4. Mexico: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.7.6.5. Mexico: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.7.7. Infectious Disease Diagnostic Market - Brazil
- 10.7.7.1. Brazil: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.7.7.2. Brazil.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.7.7.3. Brazil: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.7.7.4. Brazil: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.7.7.5. Brazil: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 10.7.8. Infectious Disease Diagnostic Market - Argentina
- 10.7.8.1. Argentina: Infectious Disease Diagnostic Market, by Product, 2019-2032 (USD Billion)
- 10.7.8.2. Argentina.: Infectious Disease Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 10.7.8.3. Argentina: Infectious Disease Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 10.7.8.4. Argentina: Infectious Disease Diagnostic Market, by Type of Testing, 2019-2032 (USD Billion)
- 10.7.8.5. Argentina: Infectious Disease Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Abbott
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Becton Dickinson
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. bioMerieux
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Bio-Rad Laboratories
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Cepheid
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Danaher
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. F. Hoffmann-La Roche Ltd
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Hologic Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Luminex Corporation
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Qiagen Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Thermo Fisher Scientific Inc
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development